Effects of Metformin on Human Metabolic System, Gene Expression and Mechanism of Action

Authors

  • Yuyao Qiao

DOI:

https://doi.org/10.54097/a9b5af36

Keywords:

Metformin, Gene expression, Human metabolic system.

Abstract

Metformin, a pivotal medication in type 2 diabetes management, has garnered attention due to its multifaceted effect on the human body. This research explores the diverse effects of metformin, encompassing its role in the metabolic system, molecular mechanisms of action, and influence on gene expression. Metformin's primary mode of action involves enhancing insulin sensitivity, regulating hepatic glucose production, and modulating various metabolic pathways. Beyond glucose control, it has shown promise in addressing conditions like polycystic ovary syndrome, cancer treatment, and even COVID-19 outcomes. At the molecular level, metformin's activation of adenosine monophosphate-activated protein kinase (AMPK) orchestrates a cascade of gene expression changes, contributing to its therapeutic outcomes. However, the variability in findings across studies underscores the intricate nature of Metformin's mechanisms. This research highlights the remarkable journey of metformin, from its herbal origins to its status as a globally recognized therapy, underscoring the importance of continuous research to refine its applications and improve patient care. Understanding metformin’s multifaceted effects provides a comprehensive perspective on its broader implications for human health and well-being.

Downloads

Download data is not yet available.

References

Shenfield G. Metformin: myths, misunderstandings and lessons from history. Australian Prescriber, 2013, 36 (2).

Bailey C J, Turner R C. Metformin. New England Journal of Medicine, 1996, 334 (9): 574 - 579.

Foretz M, Guigas B, Bertrand L, et al. Metformin: from mechanisms of action to therapies. Cell metabolism, 2014, 20 (6): 953 - 966.

Lee A, Morley J E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non‐insulin‐dependent diabetes. Obesity research, 1998, 6 (1): 47 - 53.

Petchsila K, Prueksaritanond N, Insin P, et al. Effect of metformin for decreasing proliferative marker in women with endometrial cancer: a randomized double-blind placebo-controlled trial. Asian Pacific Journal of Cancer Prevention: APJCP, 2020, 21 (3): 733.

Udumula M P, Poisson L M, Dutta I, et al. Divergent metabolic effects of metformin merge to enhance eicosatetraenoic acid metabolism and inhibit ovarian cancer in vivo. Cancers, 2022, 14 (6): 1504.

Cusi K, DeFronzo R A. Metformin: a review of its metabolic effects. Diabetes Reviews, 1998, 6 (2): 89 - 131.

Bridgeman S C, Ellison G C, Melton P E, et al. Epigenetic effects of metformin: from molecular mechanisms to clinical implications. Diabetes, Obesity and Metabolism, 2018, 20 (7): 1553 - 1562.

Wheaton W W, Weinberg S E, Hamanaka R B, et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. elife, 2014, 3: e02242.

Xu X X, Zhang S S, Lin H L, et al. Metformin promotes regeneration of the injured endometrium via inhibition of endoplasmic reticulum stress-induced apoptosis. Reproductive Sciences, 2019, 26 (4): 560 - 568.

Downloads

Published

29-12-2023

How to Cite

Qiao, Y. (2023). Effects of Metformin on Human Metabolic System, Gene Expression and Mechanism of Action. Highlights in Science, Engineering and Technology, 74, 1730-1736. https://doi.org/10.54097/a9b5af36